Raymond James analyst Reni Benjamin reiterated an Outperform rating on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), following the company's report of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE